Welcome to our dedicated page for SRX Health Solutions news (Ticker: SRXH), a resource for investors and traders seeking the latest updates and insights on SRX Health Solutions stock.
SRx Health Solutions, Inc. (NYSE American: SRXH) issues frequent press releases and SEC-referenced announcements that document its transition toward a digital-asset treasury operating model and its planned acquisition of EMJ Crypto Technologies Inc. (EMJX). The news flow provides insight into how the company is reshaping its strategy around a Gen2 digital-asset treasury platform that uses quantitative models, artificial intelligence and systematic risk controls.
Recent news items describe the definitive agreement to acquire EMJX, stockholder approval for a future name change to EMJX, Inc. and a planned ticker change to EMJX upon closing of the transaction. Company announcements also cover the deployment of an initial allocation of capital into digital assets such as Bitcoin and Ethereum, which the company characterizes as part of a measured, model-driven treasury management approach rather than short-term speculation.
Other SRXH news highlights enhancements to the EMJX platform, including integration of OpenAI large language models for research and risk decision support and the use of prediction-market probability data to strengthen its internal risk-intelligence framework. Governance and capital-markets updates appear regularly, such as the appointment of new directors with experience in cannabis, capital markets and cryptocurrency treasury strategies, amendments to the company’s charter to increase authorized shares, and private placements of preferred stock and warrants.
SRXH news releases also address NYSE American listing matters, including notifications of stockholders’ equity deficiencies and acceptance of the company’s plan to regain compliance with continued listing standards. For investors tracking SRXH, the news feed offers a consolidated view of transaction milestones, treasury activities, platform development and regulatory communications. Monitoring this page helps readers follow how the company’s proposed combination with EMJX progresses and how its digital-asset treasury strategy evolves over time.
SRx Health Solutions (NYSE American: SRXH) and merger partner EMJ Crypto Technologies announced board approval to dividend 75% of profits from the Company’s investment in Astro Investment XVII, an Astro Capital SPV holding stakes in SpaceX and other AI and space companies.
The Company has invested more than 10% of its investable capital in this SPV and plans to return capital to shareholders upon its wind down. SRx Health has filed a Form S-4 Registration Statement related to its proposed transaction with EMJX.
SRx Health Solutions (NYSE American: SRXH) reported fiscal Q2 2026 results for the quarter ended March 31, 2026.
Net revenue rose 23% quarter over quarter to $3.4 million, gross margin held near 37%, and gross profit reached $1.3 million. Operating loss improved to $(1.8) million and net loss to $(6.4) million. Adjusted EBITDA loss improved 44% to $(0.6) million. Cash increased to $20.5 million, aided by equity and preferred issuances. SRx highlighted an active cryptocurrency strategy that reduced losses versus a buy-and-hold approach and a pending EMJX acquisition expected to close by fiscal Q3.
SRx Health Solutions (NYSE American: SRXH) and EMJ Crypto Technologies announced an investment of more than 10% of SRXH's investable capital into Astro Investment XVII, an Astro Capital affiliate SPV holding investments in SpaceX and other AI and space companies.
The company highlighted AI and space as long-term growth themes and reported filing a Form S-4 Registration Statement with the SEC for its proposed merger with EMJ Crypto.
SRx Health Solutions (NYSE:SRXH) invested greater than 10% of its investable capital in Astro Investment XVII, an affiliate of Astro Capital, focusing on the convergence of AI and space. The transaction accompanies a proposed merger with EMJ Crypto Technologies and a Registration Statement on Form S-4 to register common stock.
The company said the investment reflects belief in long-term AI and space value and noted investors should review the Information Statement/Prospectus and SEC filings before making decisions.
SRx Health Solutions (NYSE: SRXH) and EMJ Crypto Technologies announced an update on their proposed merger and operational progress as of April 17, 2026. EMJX deployed $18 million into a Gen2 digital-asset treasury strategy, reporting a 5.69% March 2026 return versus a 4.98% S&P 500 decline (10.67% outperformance).
The companies filed a Form S-4 registration statement with the SEC; the EMJX platform will operate as a wholly owned subsidiary and Eric M. Jackson will join as an officer post-close.
SRx Health Solutions (NYSE American: SRXH) filed a Form S-4 on April 16, 2026 in connection with its proposed merger with EMJ Crypto Technologies (EMJX) and reported recent portfolio moves and interim performance metrics.
The company disclosed open-market purchases of Compass shares, an increased investment in Opendoor, an approximate 3.5% gain in its hedging pool and an approximate 8% gain in long treasury holdings through mid-April, and said it will provide quarterly market performance metrics going forward.
SRx Health Solutions (NYSE: SRXH) reported a +5.69% return in March 2026 for its hedging pool driven by the EMJX AI engine, versus a -4.98% decline for the S&P 500. The company entered a definitive merger agreement with EMJ Crypto Technologies and intends to file a Form S-4 to register shares to be issued in the proposed transaction. The Board is considering a quarterly dividend based on a percentage of investment-portfolio profits. The company cautions investors to read the forthcoming Registration Statement and Information Statement/Prospectus.
SRx Health Solutions (NYSE American: SRXH) said it hedged its decentralized finance (DeFi) portfolio by investing in gold and reduced its hedge on emerging markets. The company has entered into a definitive merger agreement with EMJ Crypto Technologies and intends to file a Form S-4 to register stock for the proposed transaction.
The communication emphasizes the forthcoming Registration Statement, cautions investors to read the Information Statement/Prospectus, and notes no offer or solicitation is being made at this time.
SRx Health Solutions (NYSE American: SRXH) entered a definitive merger agreement with EMJ Crypto Technologies (EMJX) and has taken a hedged position on its cryptocurrency and emerging‑markets investment portfolio for volatility protection on digital assets and international revenues. The company said shareholders will be updated soon on the proposed timeline to close the EMJX transaction.
SRx Health Solutions (NYSE:SRXH) and EMJ Crypto Technologies announced the launch of EventHorizonIQ on March 9, 2026, a subscription service providing institutional-grade cross-asset regime intelligence. The product uses 22+ quantitative sensors, records regime states to an immutable ledger, and offers free and premium tiers with advanced composite signals.
The launch is described as the first proprietary product offering under EMJX’s digital-asset treasury platform and targets investors and risk professionals seeking real-time regime classification across macro and crypto domains.